Announced Mon, 19 Jan · 17:41 IST

Notice Convening EGM of the Company

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Fredun Pharmaceuticals Limited has called an EGM on Monday, February 16, 2026 at 9:00 a.m. via Video Conferencing (VC) / OAVM. The only item of business is the appointment of Ms. Pooja Narendra Sanghavi (DIN: 11387388) as Non-Executive Independent Director for a 5-year term from November 28, 2025 to November 27, 2030, to be passed as a Special Resolution. Ms. Sanghavi is 27 years old, a Company Secretary with over 5 years of experience in corporate law, SEBI LODR regulations, and compliance functions, and holds zero equity shares in the company. She was initially appointed as Additional Director on November 28, 2025, and this EGM seeks shareholder approval within the three-month window required under SEBI's Listing Regulations. The register of members will be closed from February 10 to February 16, 2026, with remote e-voting open from February 13 to February 15, 2026, and a cut-off date of February 9, 2026.

Likely market impact

This is a routine corporate governance filing to regularize an independent director's appointment. No material impact on share price is expected; shareholders just need to vote on the resolution during the e-voting window.